These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 2404820)
1. Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy. Senter PD FASEB J; 1990 Feb; 4(2):188-93. PubMed ID: 2404820 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Senter PD; Saulnier MG; Schreiber GJ; Hirschberg DL; Brown JP; Hellström I; Hellström KE Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4842-6. PubMed ID: 3387440 [TBL] [Abstract][Full Text] [Related]
9. Targeting enzymes for cancer therapy: old enzymes in new roles. Deonarain MP; Epenetos AA Br J Cancer; 1994 Nov; 70(5):786-94. PubMed ID: 7947082 [TBL] [Abstract][Full Text] [Related]
10. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Connors TA Gene Ther; 1995 Dec; 2(10):702-9. PubMed ID: 8750009 [TBL] [Abstract][Full Text] [Related]
11. Antibody-enzyme conjugates for cancer therapy. Melton RG; Sherwood RF J Natl Cancer Inst; 1996 Feb; 88(3-4):153-65. PubMed ID: 8632489 [TBL] [Abstract][Full Text] [Related]